Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

279
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
279

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing third-line and beyond therapies for metastatic colorectal cancer in Taiwan: an evidence-based consensus.

Therapeutic advances in medical oncology·2026
Same author

Emergence of invasive <i>Escherichia coli</i> pathobionts in gut microbiome promotes cancer stemness via targeting Hippo pathways.

Gut microbes·2026
Same author

Conversion-intent definitive liver-directed therapy improves survival in liver-predominant metastatic colorectal cancer.

American journal of cancer research·2026
Same author

Serum and tissue IGFBP2 as a prognostic biomarker in gastric adenocarcinoma: A multi-cohort clinical validation study.

Journal of the Formosan Medical Association = Taiwan yi zhi·2026
Same author

SN38 PLGA nanoparticles provide sustained antitumor efficacy and ameliorate colitis severity in a murine colitis-associated cancer model.

International journal of pharmaceutics: X·2026
Same author

Epigenetic reprogramming of hexokinase domain containing 1 (HKDC1) promotes proliferation in colorectal cancer.

American journal of cancer research·2026

Related Experiment Video

Updated: Nov 6, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

479

Recurrence Outcomes Less Favorable in T1 Rectal Cancer than in T1 Colon Cancer.

Li-Chun Chang1,2, Chia-Tung Shun3, Been-Ren Lin4

  • 1Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

The Oncologist
|May 6, 2021
PubMed
Summary

T1 colorectal cancer in the rectum has a higher recurrence risk than in the colon. Rectal location is an independent risk factor for recurrence, indicating less favorable outcomes.

Keywords:
Anatomic locationColorectal cancerDisease-free survivalT1 cancer

More Related Videos

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.0K
The Influence of Liver Resection on Intrahepatic Tumor Growth
07:55

The Influence of Liver Resection on Intrahepatic Tumor Growth

Published on: April 9, 2016

9.6K

Related Experiment Videos

Last Updated: Nov 6, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

479
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.0K
The Influence of Liver Resection on Intrahepatic Tumor Growth
07:55

The Influence of Liver Resection on Intrahepatic Tumor Growth

Published on: April 9, 2016

9.6K

Area of Science:

  • Oncology
  • Gastroenterology
  • Surgical Oncology

Background:

  • Screening programs increase early-stage colorectal cancer diagnoses, including T1 cancer.
  • Current treatment for T1 cancer does not vary by anatomical location.
  • This study compares disease-free survival for T1 cancer in the rectum versus the colon.

Purpose of the Study:

  • To compare disease-free survival between T1 rectal cancer and T1 colon cancer.
  • To identify risk factors for recurrence in T1 colorectal cancer based on location.

Main Methods:

  • A hospital-based study of 343 patients with T1 cancer (2005-2014).
  • Review of clinical, colonoscopy, and histopathology data with a mean follow-up of 7.1 years.
  • Kaplan-Meier and Cox regression analyses were used to compare recurrence risk and identify risk factors.

Main Results:

  • T1 rectal cancer showed a significantly higher risk of recurrence compared to T1 colon cancer (p=0.022).
  • Rectal location (HR=4.84) and larger neoplasm size (HR=1.32) were independent risk factors for recurrence.
  • No significant difference in advanced histology occurrence between T1 rectal and colon cancers (p=0.58).

Conclusions:

  • T1 cancers originating in the rectum have poorer recurrence outcomes than those in the colon.
  • Further research is needed to evaluate adjuvant radiotherapy or chemotherapy for T1 rectal cancer to reduce recurrence risk.